Assays for Analyte Homologs

• US 20140308751A1
• Filed: 04/12/2013
• Published: 10/16/2014
• Est. Priority Date: 04/12/2013
• Status: Abandoned Application

• Current Assignee: Siemens Healthcare Diagnostics Incorporated (Siemens AG)
• Original Assignee: Siemens Healthcare Diagnostics Incorporated (Siemens AG)
• Inventors: Wei, Tie Q., Bedzyk, William, Garcia, Elsa
• Application Number:
  US13/861,422
• Publication Number:
  US 20140308751A1
• Time in Patent Office: Days
• US Class Current: 436/501
• CPC Class Codes: G01N 33/82 involving vitamins or their receptors

Abstract

Methods include adjusting a contribution of one of two analyte homologs to an amount of signal obtained in an assay for determining a total amount of the two analyte homologs in a sample. A non-assay receptor is employed that has a greater binding affinity for whichever of the two analyte homologs whose contribution to the amount of signal is to be adjusted. An amount of the non-assay receptor is sufficient to achieve an adjustment of the contribution of the analyte homolog to the signal. The assay for determining the total amount of the two analyte homologs is conducted where the assay utilizes at least one assay antibody.

Claims

1. A method of adjusting a contribution of one of two analyte homologs to an amount of signal obtained in an assay for determining a total amount of the two analyte homologs in a sample, the method comprising:

(a) providing in combination in an assay medium;

(i) a sample suspected of containing the two analyte homologs,

(ii) reagents for conducting an assay for determining the total amount of the two analyte homologs in the sample, wherein the reagents comprises at least one assay receptor that binds to the two analyte homologs, and

(iii) a non-assay receptor that has a greater binding affinity for whichever of the two analyte homologs whose contribution to the amount of signal is to be adjusted, wherein an amount of the non-assay receptor is sufficient to achieve an adjustment of the contribution of the analyte homolog to the signal; and

(b) conducting the assay for determining the total amount of the two analyte homologs.

2. The method according to claim 1, wherein the amount of the non-assay receptor is sufficient to achieve an adjustment of the contribution to the signal so that the amount of signal obtained in the assay accurately represents the total amount of the two analyte homologs in the sample.

3. The method according to claim 1, wherein the non-assay receptor has a greater binding affinity for whichever of the two homologs that would otherwise result in an overestimation of its amount in a sample, wherein an amount of the non-assay receptor is sufficient such that the amount of signal accurately reflects the total amount of the two analyte homologs in the sample.

4. The method according to claim 1 wherein the first analyte homolog and the second analyte homolog are 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃.

5. The method according to claim 1 wherein the reagents for conducting the assay further comprise an analog of the analyte wherein the analog comprises a label.

6. The method according to claim 1 wherein the reagents for conducting the assay further comprise a particle.

7. The method according to claim 1 wherein the reagents for conducting the assay further comprise a photosensitizer reagent and a chemiluminescent particle.

8. The method according to claim 7 wherein the photosensitizer reagent comprises a particle.

9. A method of determining in a sample an amount of a first analyte homolog and a second analyte homolog, the method comprising:

(a) providing in combination in an assay medium;

(i) a sample suspected of containing the first analyte homolog and the second analyte homolog,

(ii) reagents for conducting an assay for the first analyte homolog and the second analyte homolog wherein the reagents comprise an assay antibody capable of binding to each of the first analyte homolog and the second analyte homolog to form complexes and a member of a signal producing system that produces a signal in relation to the amount of the first analyte homolog and the second analyte homolog in the complexes, and

(iii) a non-assay receptor that has a greater binding affinity for whichever of the first analyte homolog or the second analyte homolog whose contribution to the amount of signal is to be adjusted, wherein an amount of the non-assay receptor is sufficient to achieve an adjustment of the contribution of the first analyte homolog or the second analyte homolog to the signal;

(b) incubating the assay medium under conditions for forming the complexes,

(c) determining the amount of signal from the complexes, and relating the amount of signal to the amount of the first analyte homolog and the second analyte homolog in the sample.

10. The method according to claim 9 wherein the first analyte homolog and the second analyte homolog are 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃.

11. The method according to claim 9 wherein the member of the signal producing system is an analyte analog that comprises a label.

12. The method according to claim 9 wherein reagents for conducting the assay further comprise a particle.

13. The method according to claim 9 wherein the member of the signal producing system comprises a photosensitizer reagent and the assay reagents further comprise a chemiluminescent particle.

14. The method according to claim 13 wherein the photosensitizer reagent comprises a particle.

15. A method of determining in a sample a total amount of 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃, the method comprising:

(a) providing in combination in an assay medium;

(i) a sample suspected of containing 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃,

(ii) reagents for conducting an assay for 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃ wherein the reagents comprise an assay antibody capable of binding to 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃ to form complexes and a member of a signal producing system that produces a signal in relation to the amount of 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃ complexes, and

(iii) a non-assay antibody that has a greater binding affinity for 25-hydroxy vitamin D₂, wherein an amount of the non-assay antibody is sufficient to achieve an adjustment of the contribution of 25-hydroxy vitamin D₂ to the amount of signal;

(b) incubating the assay medium under conditions for forming the complexes,

(c) determining the amount of signal from the complexes, and relating the amount of signal to the total amount of 25-hydroxy vitamin D₂ and 25-hydroxy vitamin D₃ in the sample.

16. The method according to claim 15 wherein the member of the signal producing system is a vitamin D analyte analog that comprises a label wherein the vitamin D analog is capable of binding to the assay antibody.

17. The method according to claim 15 wherein reagents for conducting the assay further comprise a particle.

18. The method according to claim 15 wherein the member of the signal producing system comprises a photosensitizer reagent and the assay reagents further comprise a chemiluminescent particle.

19. The method according to claim 18 wherein the photosensitizer reagent comprises a particle.